| 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | Total |
---|---|---|---|---|---|---|---|---|
Myocardial infarction | 6 (27.2) | 3 (15.8) | 9 (34.6) | 5 (16.1) | 5 (12.5) | 17 (3.7) | 16 (32) | 61 (26.1) |
Others cardiomyopathies* | 1 (4.6) | 6 (31.5) | 4 (15.4) | 10 (32.2) | 11 (27.5) | 10 (22.3) | 10 (20) | 52 (22.3) |
Ischemia | 6 (27.2) | 2 (10.5) | 5 (19.2) | 3 (9.6) | 7 (17.5) | 5 (11.2) | 6 (12) | 34 (14.5) |
Myocardial viability | 5 (22.7) | 3 (15.8) | 2 (7.6) | 1 (3.3) | 6 (15) | 4 (8.9) | 6 (12) | 27 (11.6) |
Hypertrophic Cardiomyopathy | 2 (9.1) | 4 (21.1) | 1 (3.9) | 2 (6.5) | 5 (12.5) | 3 (6.6) | 7 (14) | 24 (10.3) |
Myocarditis | 1 (4.6) | 0 (0) | 0 (0) | 1 (3.3) | 0 (0) | 0 (0) | 0 (0) | 2 (1.0) |
Pulmonary Hypertension | 1 (4.6) | 1 (5.3) | 0 (0) | 1 (3.3) | 0 (0) | 2 (4.3) | 0 (0) | 5 (2.1) |
Valvular disease | 0 (0) | 0 (0) | 2 (7.7) | 0 (0) | 1 (2.5) | 1 (2.3) | 1 (2) | 5 (2.1) |
Cardiac mass | 0 (0) | 0 (0) | 1 (3.9) | 3 (9.6) | 1 (2.5) | 0 (0) | 0 (0) | 5 (2.1) |
Others | 0 (0) | 0 (0) | 2 (7.7) | 5 (16.1) | 4 (10) | 3 (6.7) | 4 (8) | 18 (7.9) |
Total | 22 (100) | 19 (100) | 26 (100) | 31 (100) | 40 (100) | 45 (100) | 50 (100) | 233 (100) |